Design Features that Affect Psychopharmacology Trials

E-ISSN： 1875-628x|2|7|546-550

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.7, 2005-11, pp. : 546-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges in Child and Adolescent Psychopharmacology Clinical Trials

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 3, 2013-06 ,pp. : 1-4

Guilford Publications Inc

Access to resources Recommend Favorite

Prevention Trials: Design and Analysis Considerations

By Drye Lea T. Meinert Curtis L.

Pharmaceutical Medicine, Vol. 25, Iss. 6, 2011-12 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

Pharmacogenetics in randomized controlled trials: considerations for trial design

By van der Baan Frederieke H Klungel Olaf H Egberts Antoine CG Leufkens Hubert G Grobbee Diederick E Roes Kit CB Knol Mirjam J

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1485-1492

Future Medicine

Access to resources Recommend Favorite

Relation of Study Design to Recruitment and Retention in CTN Trials

By Wakim Paul G. Rosa Carmen Kothari Prasad Michel Mary Ellen

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 426-433

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics and psychopharmacology

By Bondy B. Zill P.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 72-78

Elsevier

Access to resources Recommend Favorite